Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 52: 634-642, 2006. First published February 23, 2006; 10.1373/clinchem.2005.048983
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplements
Right arrow All Versions of this Article:
clinchem.2005.048983v1
52/4/634    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mitsuhashi, M.
Right arrow Articles by Shinagawa, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mitsuhashi, M.
Right arrow Articles by Shinagawa, A.
Related Collections
Right arrow Molecular Diagnostics and Genetics
(Clinical Chemistry. 2006;52:634-642.)
© 2006 American Association for Clinical Chemistry, Inc.

Molecular Diagnostics and Genetics

Quantification of mRNA in Whole Blood by Assessing Recovery of RNA and Efficiency of cDNA Synthesis

Masato Mitsuhashi1,2,a, Shigeru Tomozawa2,3, Katsuya Endo4 and Atsushi Shinagawa5

1 Hitachi Chemical Research Center, Inc., Irvine, CA.
2 Department of Pathology, College of Medicine, University of California at Irvine, Irvine, CA.
3 Department of Surgical Oncology, Faculty of Medicine, University of Tokyo, Tokyo, Japan.
4 Hitachi Chemical Co., Ltd., Tokyo, Japan.
5 Hitachi, Ltd., Hitachi General Hospital, Hitachi, Japan.

aAddress correspondence to this author at: 1003 Health Sciences Road, Irvine, CA 92617. Fax 949-725-2727; e-mail mmitsuhashi{at}HCRcenter.com.

Background: Current gene expression analysis relies on the assumption that the isolated RNA represents all species of mRNA in proportions equal to those in the original materials. No system is available for absolute quantification of mRNA.

Methods: We applied whole blood to 96-well filterplates to trap leukocytes. Lysis buffer containing cocktails of specific reverse primers and known concentrations of synthetic external control RNA (RNA34) was added to filterplates, and cell lysates were transferred to oligo(dT)-immobilized microplates for hybridization. We then synthesized the cDNA in the oligo(dT)-immobilized microplates from these primer sites and used the cDNA for real-time PCR. RNA34 acted as a universal control, and gene amplification results were converted to quantities of mRNA per microliter of whole blood after the recovery of RNA34 in each sample was determined.

Results: Under fully optimized conditions, both added RNA34 and native mRNA species exhibited ~10% recovery from whole blood to real-time PCR. When whole blood was stimulated ex vivo, changes in gene expression as low as 30%–40% were detected with statistical significance, and the experimental CVs were low (10%–20%).

Conclusion: This new system to estimate mRNA copies per microliter of whole blood may allow standardization of gene-expression–based molecular diagnostics.




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
H. P.Y. Fan, C. Di Liao, B. Y. Fu, L. C.W. Lam, and N. L.S. Tang
Interindividual and Interethnic Variation in Genomewide Gene Expression: Insights into the Biological Variation of Gene Expression and Clinical Implications
Clin. Chem., April 1, 2009; 55(4): 774 - 785.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. Mitsuhashi, K. Endo, K. Obara, H. Izutsu, T. Ishida, N. Chikatsu, and A. Shinagawa
Ex Vivo Simulation of the Action of Antileukemia Drugs by Measuring Apoptosis-Related mRNA in Blood
Clin. Chem., April 1, 2008; 54(4): 673 - 681.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
A. K. Chen, M. A. Behlke, and A. Tsourkas
Avoiding false-positive signals with nuclease-vulnerable molecular beacons in single living cells
Nucleic Acids Res., August 15, 2007; (2007) gkm593v1.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. Mitsuhashi
Ex Vivo Simulation of Drug Action: Quantification of Drug-Induced mRNA as a Bridge Between Preclinical and Clinical Trials
Clin. Chem., January 1, 2007; 53(1): 148 - 149.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Association for Clinical Chemistry.